ERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free ...
Waters Corporation (NYSE: WAT) today launched the ARES-G3â„¢ Rheometer, part of the TA Instruments product line. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results